Fennec Pharmaceuticals Inc
SWB:RV41
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fennec Pharmaceuticals Inc
SWB:RV41
|
US |
|
Escorts Kubota Ltd
BSE:500495
|
IN |
|
S
|
Swiss Re AG
BMV:SRENN
|
CH |
|
Y
|
Yamana Gold Inc
XETRA:RNY
|
CA |
|
D
|
DaVita Inc
XMUN:TRL
|
US |
|
A
|
Ameriprise Financial Inc
DUS:A4S
|
US |
Wall St Price Targets
RV41 Price Targets Summary
Fennec Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for RV41 is 13.51 EUR with a low forecast of 11.17 EUR and a high forecast of 16.08 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RV41's stock price target?
Price Target
13.51
EUR
According to Wall Street analysts, the average 1-year price target for RV41 is 13.51 EUR with a low forecast of 11.17 EUR and a high forecast of 16.08 EUR.
What is the Revenue forecast for Fennec Pharmaceuticals Inc?
Projected CAGR
48%
The compound annual growth rate for Revenue over the next 3 years is 48%.
What is the Gross Profit forecast for Fennec Pharmaceuticals Inc?
Projected CAGR
46%
The compound annual growth rate for Gross Profit over the next 3 years is 46%.
